BAC
Bank of America Corporation
BAC has the edge over PJT overall, supported by stronger fundamentals and stronger valuation.
PJT
PJT Partners Inc.
PJT's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
PJT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
PJT's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like PJT.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over PJT in the historical PE scenario, which offers more potential upside but is not a forecast.
PJT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $92.56 | -39% |
| Forward | 18x | $151 | — |
| Fair | 24x | $134 | -11% |
| Current | 27x | $151 | — |
| Expensive | 31x | $175 | +15% |
Historical ranges are pointers, not guarantees.
PJT's PE is in its fair range at 27x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
PJT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for PJT, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over PJT on earnings, with more consistent year-over-year improvement.
PJT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.24 | +46% |
| Q3 2026 | $5.63 | -13% |
| Q2 2026 | $5.95 | +2.2% |
| Q1 2026 | $5.50 | -3% |
| Q4 2025 | $4.15 | -15% |
| Q3 2025 | $6.50 | +9.8% |
| Q2 2025 | $5.82 | +0.2% |
| Q1 2025 | $5.67 | +1.1% |
| Q4 2024 | $4.90 | -3.2% |
PJT's earnings per share have fallen from their peak: $5.63 over the past year, against $7.89 in mid-2021.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over PJT on profitability, with a higher operating margin.
PJT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $385.1M | -14% |
| Q2 2026 | $486.3M | +20% |
| Q1 2026 | $418.2M | +29% |
| Q4 2025 | $535.2M | +12% |
| Q3 2025 | $447.1M | +37% |
| Q2 2025 | $406.9M | +13% |
| Q1 2025 | $324.5M | -1.5% |
| Q4 2024 | $477.3M | +45% |
PJT's revenue is growing: $385M last quarter, down 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | -3.7 points |
| Q2 2026 | 22% | +1.8 points |
| Q1 2026 | 19% | +1.2 points |
| Q4 2025 | 24% | +0.7 points |
| Q3 2025 | 22% | +4.3 points |
| Q2 2025 | 20% | +1.1 points |
| Q1 2025 | 18% | 0 points |
| Q4 2024 | 23% | +4.4 points |
PJT's operating margin was 18% last quarter, down 3.7 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
PJT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $267M | +11% |
| Q2 2026 | $226.4M | +27% |
| Q1 2026 | $56M | +$133.9M |
| Q4 2025 | $138.6M | -29% |
| Q3 2025 | $240.9M | +35% |
| Q2 2025 | $178.9M | -7.3% |
| Q1 2025 | -$77.9M | -$38.7M |
| Q4 2024 | $195.3M | +58% |
PJT has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
PJT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -3.4M shares |
| 1 year | -12% | -3.4M shares |
| 3 years | -5.3% | -1.4M shares |
| 5 years | -40% | -16.8M shares |
| Available history | -22% | -7.3M shares |
PJT has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $20.2M |
| Q2 2026 | $53.6M |
| Q1 2026 | $61.3M |
| Q4 2025 | $4.7M |
| Q3 2025 | — |
| Q2 2025 | $63.4M |
| Q1 2025 | $127.1M |
| Q4 2024 | $49.5M |
PJT spent $140M buying back its own shares over the past year, down 42% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
PJT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | -0.4x | Net Cash |
PJT has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
PJT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.9 | Neutral |
| Stochastic | 32.9 | Neutral |
PJT's weekly RSI is 47 (neutral) and its Stochastic is 33 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over PJT on valuation relative to its sector.
PJT PE vs Financial Services Sector
| Metric | PJT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 13x | 106% above |
| PE % | 62 | 63 | 1 pt below |
PJT is trading at 27x earnings, a 106% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
PJT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $144.4 | 4.7% above |
| 20 week MA | $159.0 | 4.9% below |
| 50 week MA | $158.2 | 4.4% below |
| 100 week MA | $160.3 | 5.6% below |
| 200 week MA | $128.9 | 17% above |
PJT has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over PJT on returns for 2026, with the stronger performance.
PJT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.8 | $77.7 | +74% |
| 2021 | $77.7 | $75.0 | -3.6% |
| 2022 | $75.0 | $76.1 | +1.5% |
| 2023 | $76.1 | $101.9 | +34% |
| 2024 | $101.9 | $159.6 | +57% |
| 2025 | $159.6 | $172.3 | +8% |
| 2026 YTD | $172.3 | $151.3 | -12% |
PJT has finished higher in five of the last six years, two of them by more than 50%. It's down 12% so far in 2026.